Guggenheim Capital’s Covetrus, Inc. Common Stock CVET Stock Holding History

Guggenheim Capital’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-31,845	Closed	-$665K	–	2043
2022 Q3	$665K	Sell	31,845 -57,879	-65%	-$1.2M	0.01%	1353
2022 Q2	$1.86M	Buy	89,724 +77,104	+611%	+$1.37M	0.01%	917
2022 Q1	$212K	Buy	+12,620	New	+$221K	﹤0.01%	2025

Other funds holding CVET

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Guggenheim Capital's CVET Position: Q4 2022 in Review

Guggenheim Capital sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 31,845 shares — an estimated $665K sold.

Guggenheim Capital first reported a position in CVET in Q1 2022 and held it in 3 quarters. The position peaked at $1.86M in Q2 2022. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

Guggenheim Capital reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Guggenheim Capital sold 31,845 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $665K.
Guggenheim Capital first reported a position in Covetrus, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
Guggenheim Capital's Covetrus, Inc. Common Stock position peaked at $1.86M in Q2 2022.
5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Guggenheim Capital's 13F filing for Q4 2022, filed 14 Feb 2023.